Eboli M L
Cancer Lett. 1985 Mar;26(2):185-90. doi: 10.1016/0304-3835(85)90025-4.
Pyruvate dehydrogenase (PDH) activity has been evaluated with respect to normal liver in 3 lines of Morris hepatomas (H), i.e. the highly differentiated H 9618A, the well differentiated H 44 and the poorly differentiated H 3924A. Assays of both total (PDHt) and active (PDHa) form show a progressive decrease of enzyme activity going from liver to the H 3924A. PDHa better correlates with the degree of hepatoma differentiation than does PDHt. Further enzyme analysis has been achieved in partially purified extracts from liver and H 3924A. The possible implications of such an enzymatic variation are discussed.
丙酮酸脱氢酶(PDH)活性已在3株莫里斯肝癌(H)中相对于正常肝脏进行了评估,即高分化的H 9618A、中分化的H 44和低分化的H 3924A。总(PDHt)活性形式和活性(PDHa)形式的检测均显示,从肝脏到H 3924A,酶活性呈逐渐下降趋势。与PDHt相比,PDHa与肝癌分化程度的相关性更好。已对肝脏和H 3924A的部分纯化提取物进行了进一步的酶分析。讨论了这种酶变化的可能影响。